Anemia of Prematurity (Detailed Protocol)

Triple Pathogenic Etiology

• 1. Impaired Erythropoiesis: Extreme blunting of renal Erythropoietin (EPO) response to tissue hypoxia due to hepatic-to-renal EPO synthesis transition phase.
• 2. Iatrogenic Phlebotomy: Massive rapid depletion of total RBC volume (neonatal blood volume is 80-90 mL/kg) from constant laboratory testing in the NICU.
• 3. Shortened RBC Lifespan: Preterm RBCs survive only 40-50 days (compared to 120 days in adults).

Clinical Hemodynamic Effects

• Often peaks at 4 to 10 weeks of life. Characterized by normocytic, normochromic reticulocytopenic anemia.
• Symptoms: Increasing absolute frequency of apnea and bradycardia (A/B spells), resting tachycardia (> 160 bpm), bounding precordium, flow murmur.
• Growth restriction: Significant poor weight gain (< 15 g/day) despite taking 120-140 kcal/kg/day, due to massive increased cardiac work compensating for low oxygen-carrying capacity.

Strict Prevention Tactics

• Delayed Cord Clamping (DCC) for 30-60 seconds at delivery minimizes the need for early postnatal transfusions by providing a placental transfusion of up to 20-30 mL/kg of whole blood.
• Umbilical Cord Milking (UCM) can be considered if DCC is contraindicated (e.g. resuscitation needed), but UCM is STRICTLY CONTRAINDICATED in infants < 28 weeks due to extreme risk of IVH.
• Perform strict micro-draw methods utilizing pediatric minimum-fill laboratory tubes.
• Utilize point-of-care (POC) testing and non-invasive sensors (transcutaneous bilirubin, continuous multi-wavelength oximetry) to drastically cut phlebotomy.

Transfusion Thresholds & Triggers

• Strict adherence to 'Liberal vs Restrictive' clinical thresholds based on respiratory status.
• Intubated / Severe pulmonary disease: Transfuse if Hgb/Hct < 11 g/dL or 35%.
• Moderate support (CPAP/Nasal Cannula / increasing O2 requirements): Transfuse if Hgb < 9-10 g/dL or 28-30%.
• Convalescent / Room Air (stable but symptomatic with apnea/poor growth): Transfuse if Hgb < 7-8 g/dL or 20-22%.
• Pharmacotherapy: Recombinant Erythropoietin (rEPO) is NO LONGER universally recommended in early courses due to association with increasing severity of Retinopathy of Prematurity (ROP).

Diagnostic & Management Algorithm

• AOP Management: [START] Hgb < 8 + Apnea/Tachycardia -> [ACTION] PRBC Transfusion 10-15 mL/kg -> [MONITOR] Reticulocyte count

References

1. Whyte R, Kirpalani H. Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants. Cochrane Database Syst Rev.
2. Franz AR, Engel C, Bassler D, et al. Effects of Liberal vs Restrictive Transfusion Thresholds on Survival and Neurocognitive Outcomes in Extremely Low-Birth-Weight Infants: The ETTNO Randomized Clinical Trial. JAMA.